Benefits of Extracorporeal Membrane Oxygenation for Hydrocarbon Pneumonitis

References

• Sinard J. M., Bartlett R. H. Extracorporeal life support in critical care medicine. J Crit Care 1990; 5: 265–278
   Web of Science ®Google Scholar
• Bartlett R. H., Stolar C. Extracorporeal life support: State-of-the-art 1990. Report of the Workshop on Diffusion of ECMO Technology, L. L. Wright. National Institute of Child Health and Human Development, Bethesda, MD, National Institutes of Health 1993:25–41. NIH publication no. 93–3399
   Google Scholar
• Hill J. D., O'Brien T. G., Murray J. J., et al. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 1972; 286: 629–634
   PubMed Web of Science ®Google Scholar
• Zapol W. M., Snider M. T., Hill J. D., et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242: 2193–2196
   PubMed Web of Science ®Google Scholar
• O'Rourke P. P., Krone R. K., Vacanti J. P., et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989; 84: 957–963
   PubMed Web of Science ®Google Scholar
• ECMO Registry of the Extracorporeal Life-Support Organization. University of Michigan, Ann Arbor, MI, 48105
   Google Scholar
• Tracy T. F., Jr, DeLosh T., Bartlett R. H. Extracorporeal Life Support Organization 1994. ASAIO J 1994; 40: 1017–1019
   PubMedGoogle Scholar
• Falterman K. W., Adolph V. R. Uses of extracorporeal membrane oxygenation in non-neonatal respiratory patients. An update. Surg Clin North Am 1992; 72: 1335–1345
   PubMed Web of Science ®Google Scholar
• Dagan O., Klein J., Gruenwald C., Bohn D., Barker G., Koren G. Preliminary studies on the effects of extracorporeal membrane oxygenation on the disposition of common pediatric drugs. Ther Drug Monit 1993; 15: 263–266
   PubMed Web of Science ®Google Scholar
• Cohen P., Collart L., Prober C. G., Fischer A. F., Blaschke T. F. Gentamicin pharmacokinetics in neonates undergoing extracorporeal membrane oxygenation. Pediatr Infect Dis J 1990; 9: 562–566
   PubMed Web of Science ®Google Scholar
• Dagan O., Klein J., Bohn D., Koren G. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med 1994; 22: 1099–1101
   PubMed Web of Science ®Google Scholar
• Leuschen M. P., Willett L. D., Hoie E. B., et al. Plasma fentanyl levels in infants undergoing extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 1993; 105: 885–891
   PubMed Web of Science ®Google Scholar
• Wells T. G., Fasules J. W., Taylor B. J., Kearns G. L. Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr 1992; 121: 974–980
   PubMed Web of Science ®Google Scholar
• Green T. P., Moler F. W., Goodman D. M. Probability of survival after prolonged extracorporeal membrane oxygenation in pediatric patients with acute respiratory failure. Crit Care Med 1995; 23: 1132–1139
   PubMed Web of Science ®Google Scholar
• Klein M. D., Whittlesey G. C. Extracorporeal membrane oxygenation. Pediatr Clin North Am 1994; 41: 365–384
   PubMed Web of Science ®Google Scholar
• Adolph V., Heaton J., Steiner R., Bonis S., Falterman K., Arensman R. Extracorporeal membrane oxygenation for nonneonatal respiratory failure. J Pediatr Surg 1991; 26: 326–330
   PubMed Web of Science ®Google Scholar
• Eade N. R., Taussig L. M., Marks M. I. Hydrocarbon pneumonitis. Pediatrics 1974; 54: 351–357
   PubMed Web of Science ®Google Scholar
• Gross P., McNerney J. M., Babyak N. A. Kerosene pneumonitis: An experimental study with small doses. Am Rev Respir Dis 1963; 88: 656–663
   PubMedGoogle Scholar
• Scharf S. M., Heimer D., Goldstein J. Pathologic and physiologic effects of aspiration of hydrocarbons in the rat. Am Rev Respir Dis 1981; 124: 625–629
   PubMed Web of Science ®Google Scholar
• Scharf S. M., Prinsloo I. Pulmonary mechanics in dogs given different doses of kerosene intratracheally. Am Rev Respir Dis 1982; 126: 695–700
   PubMed Web of Science ®Google Scholar
• Anas N., Namasonthi V., Ginsburg C. M. Criteria for hospitalizing children who have ingested products containing hydrocarbons. JAMA 1981; 246: 840–843
   PubMed Web of Science ®Google Scholar
• Litovitz T. L., Felberg L., Soloway R. A., Ford M., Geller R. 1994 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1995; 13: 551–597
   PubMed Web of Science ®Google Scholar
• Scalzo A. J., Weber T. R., Jaeger R. W., Connors R. H., Thompson M. W. Extracorporeal membrane oxygenation for hydrocarbon aspiration. Am J Dis Child 1990; 144: 867–871
   PubMedGoogle Scholar
• Moler F. W., Palmisano J., Custer J. R. Extracorporeal life support for pediatric respiratoryfailure: Predictors of survival from 220 patients. Crit Care Med 1993; 21: 1604–1611
   PubMed Web of Science ®Google Scholar
• Gerarde H. W. Toxicological studies on hydrocarbons. DC. The aspiration hazard and toxicity of hydrocarbons and hydrocarbon mixtures. Arch Environ Health 1963; 6: 329–341
   PubMed Web of Science ®Google Scholar
• Williamson L. M., Martinez T. T. Toxic effect of different viscosity hydrocarbons in the lung. Proc West Pharmacol Soc 1989; 32: 313–315
   PubMedGoogle Scholar
• Tamburro R. F., Bugnitz M. C., Stidham G. L. Alveolar-arterial oxygen gradient as a predictor of outcome in patients with nonneonatal pediatric respiratory failure. J Pediatr 1991; 119: 935–938
   PubMed Web of Science ®Google Scholar
• Rivera R. A., Butt W., Shann F. Predictors of mortality in children with respiratory failure: possible indications for ECMO. Anaesth Intensive Care 1990; 18: 385–389
   PubMed Web of Science ®Google Scholar
• Vernon D. D., Dean J. M., McGough E. C. Pediatric extracorporeal membrane oxygenation. The time for anecdotes is over. Am J Dis Child 1990; 144: 855–856
   PubMedGoogle Scholar
• Campbell T. G. Changing criteria for the artificial lung. Historic controls on the technology of ECMO. ASAIOJ 1994; 40: 109–120
   PubMedGoogle Scholar
• Mike V., Krauss A. N., Ross G. S. Neonatal extracorporeal membrane oxygenation (ECMO): clinical trials and the ethics of evidence. J Med Ethics 1993; 19: 212–218
   PubMed Web of Science ®Google Scholar
• Bysani G. K., Rucoba R. J., Noah Z. L. Treatment of hydrocarbon pneumonitis. High frequency jet ventilation as an alternative to extracorporeal membrane oxygenation. Chest 1994; 106: 300–303
   PubMed Web of Science ®Google Scholar
• Walsh-Sukys M., Stork E. K., Martin R. J. Neonatal ECMO: iron lung of the 1990s?. J Pediatr 1994; 124: 427–430
   PubMed Web of Science ®Google Scholar
• Shih R. D., Mercurio M., Morasco R., Hoffman R. S., Weisman R. S., Herschman J. H., Meggs W., Goldfrank L. R., Marcus S. M. Artificial surfactant administration in an animal model of hydrocarbon induced pulmonary toxicity. J Toxicol Clin Toxicol 1996; 34: 139
   Web of Science ®Google Scholar